Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Natus Medical Inc (BABY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 851,180
  • Shares Outstanding, K 33,777
  • Annual Sales, $ 530,890 K
  • Annual Income, $ -22,940 K
  • 60-Month Beta 0.54
  • Price/Sales 1.71
  • Price/Cash Flow 9.43
  • Price/Book 2.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.24
  • Growth Rate Est. (year over year) -75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.88 +2.89%
on 03/25/19
28.70 -10.80%
on 03/04/19
-2.43 (-8.67%)
since 02/25/19
3-Month
24.88 +2.89%
on 03/25/19
34.63 -26.08%
on 01/18/19
-6.13 (-19.32%)
since 12/24/18
52-Week
24.88 +2.89%
on 03/25/19
37.95 -32.54%
on 06/06/18
-9.00 (-26.01%)
since 03/23/18

Most Recent Stories

More News
Natus Medical Shares Down 19.8% Since SmarTrend's Sell Call (BABY)

SmarTrend identified a Downtrend for Natus Medical (NASDAQ:BABY) on December 17th, 2018 at $31.47. In approximately 3 months, Natus Medical has returned 19.78% as of today's recent price of $25.24.

BABY : 25.60 (+1.59%)
NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ:BABY).

BABY : 25.60 (+1.59%)
Shares of BABY Down 15.9% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Natus Medical (NASDAQ:BABY) on December 17th, 2018 at $31.47. In approximately 3 months, Natus Medical has returned 15.87% as of today's recent price of $26.47.

BABY : 25.60 (+1.59%)
Global Brain Monitoring Systems Market Outlook, 2019-2024 with Compumedics, General Electric Company, Medtronic, Natus Medical and Nihon Kohden Dominating - ResearchAndMarkets.com

The "Brain Monitoring Systems Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

BABY : 25.60 (+1.59%)
MDT : 90.62 (+0.25%)
GE : 9.88 (-1.00%)
Natus Announces Upcoming Financial Conference Schedule

Natus Medical Incorporated (NASDAQ: BABY) today announced its upcoming conference schedule for March:

BABY : 25.60 (+1.59%)
Consolidated Research: 2019 Summary Expectations for Alphabet, Aflac, Natus Medical, SPS Commerce, Semtech, and Brunswick -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alphabet Inc. (NASDAQ:GOOG),...

GOOG : 1,193.00 (-1.04%)
BC : 49.74 (+0.02%)
AFL : 49.52 (+0.12%)
BABY : 25.60 (+1.59%)
SPSC : 104.74 (-0.63%)
SMTC : 52.56 (-0.72%)
NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: BABY).

BABY : 25.60 (+1.59%)
New Strong Sell Stocks for February 15th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

USG : 43.06 (-0.12%)
BABY : 25.60 (+1.59%)
CPE : 7.34 (-1.61%)
EXEL : 23.20 (-0.09%)
LTHM : 12.71 (-1.63%)
Natus Medical (BABY) Q4 Earnings Miss Estimates

Natus Medical (BABY) delivered earnings and revenue surprises of -14.00% and 3.44%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

BABY : 25.60 (+1.59%)
Natus Medical: 4Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported a loss of $11.6 million in its fourth quarter.

BABY : 25.60 (+1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BABY with:

Business Summary

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized...

See More

Key Turning Points

2nd Resistance Point 26.27
1st Resistance Point 25.93
Last Price 25.60
1st Support Level 25.07
2nd Support Level 24.55

See More

52-Week High 37.95
Fibonacci 61.8% 32.96
Fibonacci 50% 31.42
Fibonacci 38.2% 29.87
Last Price 25.60
52-Week Low 24.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar